Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review

Maleka Najmi, Tiffaney Tran, Russell G. Witt, Kelly C. Nelson

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

For patients with metastatic melanoma, immunotherapy agents represent a promising treatment option, and researchers are actively seeking to identify factors that may predict a favorable response in patients. Recent studies have elucidated possible associations between the gut microbiome and the effects of immunotherapy, where variations in the gut microbiome may influence treatment response and frequency of adverse effects. In this clinical review, we describe the current literature related to the gut microbiome in the setting of immunotherapy, and we provide an overview of interventions under investigation that may modulate the gut microbiome. These interventions include fecal microbiota transplantation, probiotics, and dietary modifications.

Original languageEnglish (US)
Pages (from-to)2489-2497
Number of pages9
JournalDermatology and Therapy
Volume12
Issue number11
DOIs
StatePublished - Nov 2022
Externally publishedYes

Keywords

  • Advanced melanoma
  • Anti-CTLA-4
  • Anti-PD-1
  • Fecal microbiota transplantation
  • Gut microbiome
  • Immunotherapy
  • Metastatic melanoma

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review'. Together they form a unique fingerprint.

Cite this